Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Tudor Investment Corporation »

Rapport Therapeutics shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download consolidated filings csv

Download as Excel

Download consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Tudor Investment Corporation

Quarter filed	Position value	Share count	Share price at filing
2025-09-30	$331k	11k	29.70

More positions owned by Tudor Investment Corporation

Cyberark Software Ltd - US Equity (CYBR)

Doordash InC - US Equity Option Call Option (DASH)

ZsCaler InC - US Equity Option Call Option (ZS)

Guidewire Software InC - US Equity Option Call Option (GWRE)

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)

Nova Ltd - US Equity Option Call Option (NVMI)

Akamai TeChnologies InC - US Equity Option Call Option (AKAM)

InvesCo Qqq Trust Series 1 - US ETP ETF Option Call Option (QQQ)

DexCom InC - US Equity Option Call Option (DXCM)

Uber TeChnologies InC - US Equity Option Call Option (UBER)

Snowflake InC - US Equity Option Call Option (SNOW)

Live Nation Entertainment InC - US Equity (LYV)

Super MiCro Computer InC - US Equity Option Call Option (SMCI)

Spdr S&P 500 Etf Trust - US ETP ETF Option Call Option (SPY)

Nutanix InC - US Equity Option Call Option (NTNX)

View all positions for Tudor Investment Corporation

Top funds holding Rapport Therapeutics

Arch Venture Corp

Capital Research and Management Company - Division 3

Cormorant Asset Management

Goldman Sachs Group

Sofinnova Ventures

Johnson & Johnson

Baker Bros. Advisors

Vestal Point Capital

Polar Capital Holdings

View all funds holding Rapport Therapeutics

© 2025 stockzoa - Track 13F-HR Filings for Hedge Funds and Value Investors.

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z